# ABBOTT LABORATORIES (ABT) FY2025 Q1 P&L / Income Statement

- Company: ABBOTT LABORATORIES (ABT)
- Period: 2025-01-01 to 2025-03-31
- Filing: Q1 FY2025 10-Q, filed 2025-04-30, accession number 0001628280-25-021090
- Page: https://plicit.ai/financials/abt/fy2025-q1-income-statement
- Chart image: https://plicit.ai/charts/abt-fy2025-q1-income-statement-sankey.png

## Chart details: Revenue by Business Segment

Income statement for 2025-01-01 through 2025-03-31. View: Business segment. Revenue uses this breakdown; costs and expenses retain the consolidated categories.

- **Net sales**: 10,358,000,000 US dollars
- **Cost of products sold, excluding amortization of intangible assets**: 4,468,000,000 US dollars
- **Gross profit (calculated)**: 5,890,000,000 US dollars
- **Operating expenses (calculated)**: 4,197,000,000 US dollars
- **Operating earnings**: 1,693,000,000 US dollars
- **Other income (expense), net (calculated)**: 85,000,000 US dollars
- **Earnings before taxes**: 1,778,000,000 US dollars
- **Taxes on earnings**: 453,000,000 US dollars
- **Net Earnings**: 1,325,000,000 US dollars
- **Established Pharmaceuticals**: 1,260,000,000 US dollars
- **Nutritionals**: 2,146,000,000 US dollars
- **Diagnostic Products**: 2,054,000,000 US dollars
- **Medical Devices**: 4,895,000,000 US dollars
- **Amortization of intangible assets**: 420,000,000 US dollars
- **Research and development**: 716,000,000 US dollars
- **Selling, general and administrative**: 3,061,000,000 US dollars
- **Revenue before reconciliation (calculated)**: 10,355,000,000 US dollars. Sum of the reported revenue categories before the separately reported reconciliation.
- **Other**: 3,000,000 US dollars. Reported reconciliation to consolidated revenue.
- **Established Pharmaceuticals costs (calculated)**: 962,000,000 US dollars. Segment revenue less segment operating income; it includes cost of revenue and operating expenses.
- **Nutritionals costs (calculated)**: 1,752,000,000 US dollars. Segment revenue less segment operating income; it includes cost of revenue and operating expenses.
- **Diagnostic Products costs (calculated)**: 1,695,000,000 US dollars. Segment revenue less segment operating income; it includes cost of revenue and operating expenses.
- **Medical Devices costs (calculated)**: 3,286,000,000 US dollars. Segment revenue less segment operating income; it includes cost of revenue and operating expenses.
- **Reconciling items (calculated)**: 970,000,000 US dollars. Segment revenue less segment operating income; it includes cost of revenue and operating expenses.

### Chart connections

- Revenue less cost of revenue equals gross profit; gross profit less operating expenses equals operating income.
- Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit equals net income.
- Reported revenue categories plus the separately reported signed reconciliation equals consolidated revenue.

## Chart details: Revenue by Geography

- Page: https://plicit.ai/financials/abt/fy2025-q1-income-statement/revenue-by-geography
- Chart image: https://plicit.ai/charts/abt-fy2025-q1-revenue-by-geography-sankey.png

Income statement for 2025-01-01 through 2025-03-31. View: Geography. Revenue uses this breakdown; costs and expenses retain the consolidated categories.

- **Net sales**: 10,358,000,000 US dollars
- **Cost of products sold, excluding amortization of intangible assets**: 4,468,000,000 US dollars
- **Gross profit (calculated)**: 5,890,000,000 US dollars
- **Operating expenses (calculated)**: 4,197,000,000 US dollars
- **Operating earnings**: 1,693,000,000 US dollars
- **Other income (expense), net (calculated)**: 85,000,000 US dollars
- **Earnings before taxes**: 1,778,000,000 US dollars
- **Taxes on earnings**: 453,000,000 US dollars
- **Net Earnings**: 1,325,000,000 US dollars
- **UNITED STATES**: 4,168,000,000 US dollars
- **International**: 6,190,000,000 US dollars
- **Amortization of intangible assets**: 420,000,000 US dollars
- **Research and development**: 716,000,000 US dollars
- **Selling, general and administrative**: 3,061,000,000 US dollars

### Chart connections

- Revenue less cost of revenue equals gross profit; gross profit less operating expenses equals operating income.
- Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit equals net income.